US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 2.150
  • -0.060-2.71%
Close Aug 23 16:00 ET
  • 2.150
  • 0.0000.00%
Post 20:01 ET
59.02MMarket Cap-2590P/E (TTM)

Immix Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-49.52%-5.26M
-82.93%-3.83M
-53.50%-11.37M
31.42%-2.68M
-111.06%-3.09M
-542.58%-3.52M
-39.95%-2.09M
-366.13%-7.41M
-250.41%-3.9M
-2,781.24%-1.46M
Net income from continuing operations
-22.45%-4.41M
-113.41%-5.33M
-89.50%-15.6M
-35.67%-5.16M
-182.98%-4.34M
-130.24%-3.6M
-87.53%-2.5M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
Depreciation and amortization
4,701.38%24.3K
4,622.77%23.85K
156.11%5.47K
443.46%3.08K
143.99%1.38K
32.11%506
-18.55%505
-13.49%2.14K
-8.71%566
-8.71%566
Change In working capital
-313.98%-1.51M
610.34%537.1K
746.75%1.65M
525.41%1.42M
467.25%518.55K
-140.61%-365.3K
133.10%75.61K
149.92%195.21K
45.05%-334.75K
-152.31%-141.2K
-Change in receivables
285.79%96.25K
-1,162.73%-911.54K
-277.94%-893.4K
-664.45%-465.93K
-1,199.60%-380.24K
122.64%24.95K
-100.75%-72.19K
-342.03%-236.38K
-135.73%-60.95K
-37.41%-29.26K
-Change in prepaid assets
114.95%198.51K
-1,009.12%-476.99K
116.18%111.84K
215.26%1.04M
104.40%446.83K
-487.45%-1.33M
87.84%-43.01K
-37.44%-691.05K
-79.77%-898.59K
2,403.27%218.6K
-Change in payables and accrued expense
-292.53%-1.8M
908.74%1.92M
116.85%2.43M
36.72%854.22K
236.73%451.96K
40.52%937.49K
18.34%190.81K
7,865.92%1.12M
323.23%624.79K
-209.93%-330.54K
-Change in other current assets
--0
---20.42K
----
----
----
--0
--0
----
----
----
-Change in other current liabilities
---2.07K
--21.31K
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Operating cash flow
-49.52%-5.26M
-82.93%-3.83M
-53.50%-11.37M
31.42%-2.68M
-111.06%-3.09M
-542.58%-3.52M
-39.95%-2.09M
-366.13%-7.41M
-250.41%-3.9M
-2,781.24%-1.46M
Investing cash flow
Cash flow from continuing investing activities
-97.07K
-301.91K
-52.09K
-13.18K
-38.91K
0
0
0
0
Net PPE purchase and sale
---97.07K
---301.91K
---52.09K
---13.18K
---38.91K
--0
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
---97.07K
---301.91K
---52.09K
---13.18K
---38.91K
--0
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
0
13,311.62%15.95M
378.44%15.46M
38.28%586.69K
10.07M
4,527.64%4.69M
-95.92%118.92K
-82.85%3.23M
-97.73%424.28K
0
Net issuance payments of debt
----
----
--0
--0
----
----
----
-125.00%-50K
--0
--0
Net common stock issuance
--0
15,245.16%15.95M
377.24%15.7M
35.52%584.07K
--10.13M
8,824.47%4.88M
-96.43%103.92K
-82.36%3.29M
-97.69%431K
--0
Proceeds from stock option exercised by employees
--0
--2.49K
--2.62K
----
----
--0
--0
--0
----
----
Net other financing activities
----
----
-3,389.23%-234.62K
--1
---58.8K
---190.82K
--15K
---6.72K
----
----
Cash from discontinued financing activities
Financing cash flow
--0
13,311.62%15.95M
378.44%15.46M
38.28%586.69K
--10.07M
4,527.64%4.69M
-95.92%118.92K
-82.85%3.23M
-97.73%424.28K
--0
Net cash flow
Beginning cash position
155.77%29.32M
30.31%17.51M
-23.85%13.44M
15.76%19.58M
-31.24%12.65M
-39.86%11.46M
-23.85%13.44M
4,411.66%17.64M
44,423.02%16.92M
16,538.50%18.4M
Current changes in cash
-555.07%-5.35M
699.05%11.82M
196.74%4.04M
39.54%-2.1M
574.58%6.94M
280.13%1.18M
-239.05%-1.97M
-124.20%-4.18M
-119.76%-3.48M
-2,016.24%-1.46M
Effect of exchange rate changes
-36.97%8.91K
-1,744.48%-10.37K
204.97%33.09K
20,028.66%31.29K
49.57%-11.77K
366.53%14.14K
79.35%-562
-480.23%-31.52K
-125.28%-157
-567.27%-23.34K
End cash Position
89.47%23.98M
155.77%29.32M
30.31%17.51M
30.31%17.51M
15.76%19.58M
-31.24%12.65M
-39.86%11.46M
-23.85%13.44M
-23.85%13.44M
44,423.02%16.92M
Free cash flow
-52.28%-5.35M
-97.36%-4.13M
-54.20%-11.42M
31.08%-2.69M
-113.72%-3.13M
-542.58%-3.52M
-39.95%-2.09M
-365.90%-7.41M
-250.41%-3.9M
-2,781.24%-1.46M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -49.52%-5.26M-82.93%-3.83M-53.50%-11.37M31.42%-2.68M-111.06%-3.09M-542.58%-3.52M-39.95%-2.09M-366.13%-7.41M-250.41%-3.9M-2,781.24%-1.46M
Net income from continuing operations -22.45%-4.41M-113.41%-5.33M-89.50%-15.6M-35.67%-5.16M-182.98%-4.34M-130.24%-3.6M-87.53%-2.5M66.25%-8.23M83.30%-3.8M-280.66%-1.54M
Depreciation and amortization 4,701.38%24.3K4,622.77%23.85K156.11%5.47K443.46%3.08K143.99%1.38K32.11%506-18.55%505-13.49%2.14K-8.71%566-8.71%566
Change In working capital -313.98%-1.51M610.34%537.1K746.75%1.65M525.41%1.42M467.25%518.55K-140.61%-365.3K133.10%75.61K149.92%195.21K45.05%-334.75K-152.31%-141.2K
-Change in receivables 285.79%96.25K-1,162.73%-911.54K-277.94%-893.4K-664.45%-465.93K-1,199.60%-380.24K122.64%24.95K-100.75%-72.19K-342.03%-236.38K-135.73%-60.95K-37.41%-29.26K
-Change in prepaid assets 114.95%198.51K-1,009.12%-476.99K116.18%111.84K215.26%1.04M104.40%446.83K-487.45%-1.33M87.84%-43.01K-37.44%-691.05K-79.77%-898.59K2,403.27%218.6K
-Change in payables and accrued expense -292.53%-1.8M908.74%1.92M116.85%2.43M36.72%854.22K236.73%451.96K40.52%937.49K18.34%190.81K7,865.92%1.12M323.23%624.79K-209.93%-330.54K
-Change in other current assets --0---20.42K--------------0--0------------
-Change in other current liabilities ---2.07K--21.31K--------------0--0------------
Cash from discontinued investing activities
Operating cash flow -49.52%-5.26M-82.93%-3.83M-53.50%-11.37M31.42%-2.68M-111.06%-3.09M-542.58%-3.52M-39.95%-2.09M-366.13%-7.41M-250.41%-3.9M-2,781.24%-1.46M
Investing cash flow
Cash flow from continuing investing activities -97.07K-301.91K-52.09K-13.18K-38.91K0000
Net PPE purchase and sale ---97.07K---301.91K---52.09K---13.18K---38.91K--0--0--0--0----
Cash from discontinued investing activities
Investing cash flow ---97.07K---301.91K---52.09K---13.18K---38.91K--0--0--0--0----
Financing cash flow
Cash flow from continuing financing activities 013,311.62%15.95M378.44%15.46M38.28%586.69K10.07M4,527.64%4.69M-95.92%118.92K-82.85%3.23M-97.73%424.28K0
Net issuance payments of debt ----------0--0-------------125.00%-50K--0--0
Net common stock issuance --015,245.16%15.95M377.24%15.7M35.52%584.07K--10.13M8,824.47%4.88M-96.43%103.92K-82.36%3.29M-97.69%431K--0
Proceeds from stock option exercised by employees --0--2.49K--2.62K----------0--0--0--------
Net other financing activities ---------3,389.23%-234.62K--1---58.8K---190.82K--15K---6.72K--------
Cash from discontinued financing activities
Financing cash flow --013,311.62%15.95M378.44%15.46M38.28%586.69K--10.07M4,527.64%4.69M-95.92%118.92K-82.85%3.23M-97.73%424.28K--0
Net cash flow
Beginning cash position 155.77%29.32M30.31%17.51M-23.85%13.44M15.76%19.58M-31.24%12.65M-39.86%11.46M-23.85%13.44M4,411.66%17.64M44,423.02%16.92M16,538.50%18.4M
Current changes in cash -555.07%-5.35M699.05%11.82M196.74%4.04M39.54%-2.1M574.58%6.94M280.13%1.18M-239.05%-1.97M-124.20%-4.18M-119.76%-3.48M-2,016.24%-1.46M
Effect of exchange rate changes -36.97%8.91K-1,744.48%-10.37K204.97%33.09K20,028.66%31.29K49.57%-11.77K366.53%14.14K79.35%-562-480.23%-31.52K-125.28%-157-567.27%-23.34K
End cash Position 89.47%23.98M155.77%29.32M30.31%17.51M30.31%17.51M15.76%19.58M-31.24%12.65M-39.86%11.46M-23.85%13.44M-23.85%13.44M44,423.02%16.92M
Free cash flow -52.28%-5.35M-97.36%-4.13M-54.20%-11.42M31.08%-2.69M-113.72%-3.13M-542.58%-3.52M-39.95%-2.09M-365.90%-7.41M-250.41%-3.9M-2,781.24%-1.46M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg